Brief: Silexion Therapeutics Corp - Phase 2/3 Trials To Start In First Half Of 2026
04/09/2025 16:05
Sept 4 (Reuters) - Silexion Therapeutics Corp SLXN.O: SILEXION THERAPEUTICS ANNOUNCES SELECTION OF CONTRACT RESEARCH ORGANIZATION TO SUPPORT UPCOMING PHASE 2/3 CLINICAL TRIALS FOR SIL204 SILEXION THERAPEUTICS CORP - PHASE 2/3 TRIALS TO START IN FIRST HALF OF 2026 Source text: ID:nGNX5VSqxM Further company coverage: SLXN.O ((Reuters.Briefs@thomsonreuters.com;))